世衛組織宣稱 中國濫用抗生素或致每年百萬人早死

The World Health Organization is calling for drug-resistant infections to be tackled globally, and says 10 million people could die each year by 2050, with the cumulative economic loss reaching 100 trillion dollars if the trend continues.

世界衛生組織近日針對全球範圍內的耐藥菌感染髮出呼籲，稱如果這種趨勢一直延續下去，到2050年，每年將有一千萬人死亡，造成的經濟損失將累計達一百萬億美元。

The WHO cited Lord Jim O'Neill's statistical and monetary predictions from the UK's Review on Antimicrobial Resistance held in May last year.

世界衛生組織援引了英國的吉姆·奧尼爾爵士根據去年五月的《全球抗菌素耐藥回顧》做出的數據及經濟預測。

Antibiotic abuse is growing more severe in China. It is estimated that antimicrobial resistance could drive one million people to early deaths annually by 2050, the latest report from the WHO said. The economic cost could soar to 20 trillion dollars.

抗生素濫用的情況在中國越來越嚴重。世界衛生組織最近的報告顯示，據估計，到2050年，抗菌素耐藥性每年會導致一百萬中國人早死。而中國的經濟損失也會達到20萬億美元。

According to the WHO, the major reasons for antimicrobial resistance in China include prevalent use of non-prescription drugs, excessive use of antibiotics in medical treatment and infection control, and the use of drugs in the promotion of livestock growth.

根據世界衛生組織表示，在中國，抗菌素耐藥性產生的主要原因包括普遍使用非處方藥、抗生素在醫療及感染控制中的過度使用以及促進家畜生長的藥物使用等。

Due to incentives for prescribing excess drugs in China, it is not easy to cultivate the idea of proper antibiotic use. The lack of antibiotic supervision in agriculture is also exacerbating the problem.

由於中國對過量的藥物處方的激勵，想要樹立正確的抗生素使用觀並不容易。農業中對抗生素使用的監管缺失也是問題加劇的原因之一。

The WHO said in the future there will more deaths caused by antimicrobial resistance than cancer.

世界衛生組織表示，在未來因抗菌素耐藥性造成的死亡人數將會超過癌症。

To tackle the health threats caused by antimicrobial resistance, the WHO suggests that patients need to consider if it is really necessary to use antibiotics. Meanwhile, the drug industry also needs encouragement to develop new antibiotics so that newly-developed drugs are able to replace the old drugs when they become ineffective.

爲應對抗菌素耐藥性帶來的健康威脅，世界衛生組織建議，病人應考慮是否真的有使用抗生素的必要。同時，也需要激勵藥品行業研發新的抗生素，這樣新開發的藥物在舊的藥物失去效力時就能起到代替的作用。